Profile
Glen C.
MacDonald is currently the President, CEO, CFO & Director at Leucadia Finance Partners, Inc. He was previously the Chief Scientific Officer at Viventia Biotech, Inc. from 2005 to 2012 and again from 2012 to 2016.
He was also the Chief Scientific Officer at Sesen Bio, Inc. from 2016 to 2017.
Additionally, he held a position as Principal at Princess Margaret Hospital Foundation and The University of North Carolina at Charlotte.
Dr. MacDonald received his undergraduate degree from the University of Guelph in 1980, his graduate degree from the University of Manitoba in 1987, and his doctorate from the University of Manitoba in 1993.
Glen MacDonald active positions
| Companies | Position | Start |
|---|---|---|
Leucadia Finance Partners, Inc.
Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Provides investment services | Chief Executive Officer | - |
Former positions of Glen MacDonald
| Companies | Position | End |
|---|---|---|
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Focuses on designing, engineering and developing targeted protein therapeutics | Chief Tech/Sci/R&D Officer | 31/08/2016 |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Chief Tech/Sci/R&D Officer | 31/12/2011 |
| CARISMA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Princess Margaret Hospital Foundation | Corporate Officer/Principal | - |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Glen MacDonald
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Health Technology |
Leucadia Finance Partners, Inc.
Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princess Margaret Hospital Foundation | |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Focuses on designing, engineering and developing targeted protein therapeutics | Health Technology |
- Stock Market
- Insiders
- Glen MacDonald
















